Walleye Trading’s Immunic IMUX Stock Holding History

Walleye Trading’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1	Closed	-$3K	–	5093
2016 Q2	$3K	Buy	+1	New	+$3.29K	﹤0.01%	5068
2015 Q4	–	Sell	-7	Closed	-$12K	–	5455
2015 Q3	$12K	Buy	+7	New	+$35K	﹤0.01%	4316

Other funds holding IMUX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Walleye Trading's IMUX Position: Q3 2016 in Review

Walleye Trading sold out of Immunic (IMUX) in Q3 2016, closing a stake of 1 share — an estimated $3K sold.

Walleye Trading first reported a position in IMUX in Q3 2015 and held it in 2 quarters. The position peaked at $12K in Q3 2015. 51 funds tracked by Wall St. Rank hold IMUX as of Q3 2016.

Walleye Trading reported no remaining Immunic position as of Q3 2016 after selling out during the quarter.
Walleye Trading sold 1 Immunic share in Q3 2016, an estimated $3K.
Walleye Trading first reported a position in Immunic in Q3 2015 and held it in 2 quarters.
Walleye Trading's Immunic position peaked at $12K in Q3 2015.
51 funds tracked by Wall St. Rank held Immunic as of Q3 2016.

Based on Walleye Trading's 13F filing for Q3 2016, filed 14 Nov 2016.